Skip to main content
SpringerLink
Log in

Effects of citalopram on dopamine D2 receptor expression in the rat brain striatum

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Effects of citalopram on dopamine D2 receptor expression in the rat brain striatum were studied. Repeated administration of citalopram increased the amount of dopamine D2 receptors, the level of dopamine D2 receptor mRNA, and the transcription rate of the dopamine D2 receptor gene. Single administration of citalopram also increased the level of dopamine D2 receptor mRNA with a maximum effect in 2–4 h after the treatment, and the transcription rate of the dopamine D2 receptor gene. The administration of 5-hydroxytryptophan (5-HTP) also increased the level of dopamine D2 receptor mRNA. These results suggest that the increase in the dopamine D2 receptor expression induced by citalopram may be owing, at least partially, to the stimulation of the dopamine D2 receptor gene transcription, and that serotonin (5-HT) may mediate the effects of citalopram in the induction of dopamine D2 receptor expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ainsworth K., Smith S. E., Zetterström T. S. C., Pei Q., Franklin M., and Sharp T. (1998) Effects of antidepressant drugs on D1 and D2 receptor expression and dopamine release in the nucleus accumbence of the rat. Psychopharmacology 140, 470–477.

    Article  PubMed  CAS  Google Scholar 

  • Arnt J., Overø K. F., Hyttel J., and Olsen R. (1984) Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram. Psychopharmacology 84, 457–465.

    Article  PubMed  CAS  Google Scholar 

  • Barker E. L. and Blakely R. D. (1995) Norepinephrine and serotonin transporters molecular targets of antidepressant drugs, in Psychopharmacology (Bloom, F. E. and Kupfer, D. J., eds.), Raven, New York, pp. 321–333.

    Google Scholar 

  • Brunello N., Barbaccia M. L., Chuang D. M., and Costa E. (1982) Down-regulation of β-adrenergic receptors following repeated injections of desmethy limipramine: permissive role of serotonergic axons. Neuropharmacol. 21, 1145–1149.

    Article  CAS  Google Scholar 

  • Bunzow J. R., Van Tol H. H. M., Grandy D. K., Albert P., Salon J., Christie M., et al. (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336, 783–787.

    Article  PubMed  CAS  Google Scholar 

  • Dewar K. M., Soghomonian J.-J., Bruno J. P., Descarries L., and Reader T. A. (1990) Elevation of dopamine D2 but not D1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536, 287–296.

    Article  PubMed  CAS  Google Scholar 

  • Dziedzicka-Wasylewska M., Rogoż R., Klimek V., and Maj J. (1997) Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain. J. Neural. Transm. 104, 515–524.

    Article  PubMed  CAS  Google Scholar 

  • Farooqui S. M., Prasad C., and Ali M. (1992) Production and characterization of a monoclonal antibody to dopamine D2 receptor: comparison with a polyclonal antibody to a different epitope. Biochem. Biophys. Res. Commun. 184, 661–667.

    Article  PubMed  CAS  Google Scholar 

  • Gundlah C., Hjorth S., and Auerbach S. B. (1997) Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology 36, 475–482.

    Article  PubMed  CAS  Google Scholar 

  • Hjorth S., Westlin D., and Bengtsson H. J. (1977) Way100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology 36, 461–465.

    Article  Google Scholar 

  • Hughes Z. A. and Stanford S. C. (1998) Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenaline uptake sites with different sensitivities to SSRIs. Br. J. Pharmacol. 124, 1141–1148.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel J. (1977) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology 51, 225–233.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel J. (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6, 277–295.

    Article  PubMed  CAS  Google Scholar 

  • Hyttel J., Overø K. F., and Arnt J. (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83, 20–27.

    Article  PubMed  CAS  Google Scholar 

  • Invernizzi R., Bramante M., and Samanin R. (1995) Extracellular concentration of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res. 696, 62–66.

    Article  PubMed  CAS  Google Scholar 

  • Invernizzi R., Velasco C., Bramante M., Longo A., and Samanin R. (1997) Effects of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36, 467–473.

    Article  PubMed  CAS  Google Scholar 

  • Janowsky A., Okada F., Manier D. H., Applegate C. D., Sulser F., and Steranka L. R. (1982) Role of serotonergic input in the regulation of the β-adrenergic receptor-coupled adenylate cyclase system. Science 218, 900,901.

    Article  PubMed  CAS  Google Scholar 

  • Kameda K. (1995) Thyroid hormone inhibits fatty acid synthase gene transcription in chicken liver. Mol. Cell. Biochem. 144, 105–108.

    Article  PubMed  CAS  Google Scholar 

  • Klimek V. and Nielsen M. (1987) Chronic treatment with antidepressants decreases the number of [3H]SCH23390 binding sites in the rat striatum and limbic system. Eur. J. Pharmacol. 139, 163–169.

    Article  PubMed  CAS  Google Scholar 

  • Koe B. K., Weissman A., Welch W. M., and Browne R. G. (1983) Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J. Pharmacol. Exp. Ther. 226, 686–700.

    PubMed  CAS  Google Scholar 

  • Maj J., Rogóż Z., Skuza G., and Sowinska H. (1984) Repeated treatment with antidepressant drugs increases the behavioral response to apmorphine. J. Neural Transm. 60, 273–282.

    Article  PubMed  CAS  Google Scholar 

  • Maj J., Dziedzicka-Wasylewska M., Rogoż R., Rogóż Z, and Skuza, G. (1996) Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptor in the rat striatum. Eur. J. Pharmacol. 304, 49–54.

    Article  Google Scholar 

  • Matsubara S., Matsubara R., Kusumi I., Koyama T., and Yamasita I. (1993) Dopamine D1, D2, and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vitro. J. Pharmacol. Exp. Ther. 265, 498–508.

    PubMed  CAS  Google Scholar 

  • Mitchell P. J. and Tjian R. (1989) Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245, 371–378.

    Article  PubMed  CAS  Google Scholar 

  • Moret C. and Briley M. (1996) Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur. J. Pharmacol. 295, 189–197.

    Article  Google Scholar 

  • Okada F., Saito Y., Fujieda T., and Yamasita I. (1972) Monoamine changes in the brain of rats injected with L-5-hydroxytryptophan. Nature 238, 355, 356.

    Article  PubMed  CAS  Google Scholar 

  • Peterson B. and Mørk A. (1996) Chronic treatment with citalopram induces noradrenaline receptor hypoactivity. A microdialysis study. Eur. J. Pharmacol. 300, 67–70.

    Article  Google Scholar 

  • Prywes R. and Roeder R. G. (1986) Inducible binding of a factor to the c-fos enhancer. Cell 47, 777–784.

    Article  PubMed  CAS  Google Scholar 

  • Ramamoorthy S., Bauman A. L., Moore K. R., Han H., Yang Feng T., Chang A. S., et al. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90, 2542–2546.

    Article  PubMed  CAS  Google Scholar 

  • Sakata M., Farooqui S. M., and Prasad C. (1992) Post-transcriptional regulation of loss of rat striatal D2 dopamine receptor during aging. Brain Res. 575, 309–314.

    Article  PubMed  CAS  Google Scholar 

  • Seeman P. (1995) Dopamine receptors: clinical correlates, in Psychopharmacology (Bloom, F. E. and Kupfer, D. J., eds.), Raven, New York, pp. 295–302.

    Google Scholar 

  • Seo H., Yang C., Kim H. S., and Kim K. S. (1996) Multiple protein factors interact with the cisregulatory elements of the proximal promoter in a cell-specific manner and regulate transcription of the dopamine β-hydroxylase gene. J. Neurosci. 16, 4102–4112.

    Google Scholar 

  • Thomas D. R., Nelson D. R., and Johnson A. M. (1987) Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 93, 193–200.

    Article  PubMed  CAS  Google Scholar 

  • Thorre K., Ebinger G., and Michotte Y. (1998) 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study. Brain Res. 796, 117–124.

    Article  PubMed  CAS  Google Scholar 

  • Tso J. Y., Sun X.-H., Kao T.-h., Reece K. S., and Wu R. (1985) Isolation and characterization of rat human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acid Res. 13, 2485–2502.

    Article  PubMed  CAS  Google Scholar 

  • Valdenaire O., Vernier P., Maus M., Dumas Milne Edwards J.-B., and Mallet J. (1994) Transcription of the dopamine-D2-receptor gene from two promoters. Eur. J. Biochem. 220, 577–584.

    Article  PubMed  CAS  Google Scholar 

  • Willner P. (1995) Dopaminergic mechanism in depression and mania, in Psychopharmacology (Bloom F. E. and Kupfer D. J., eds.), Raven, New York, pp. 921–931.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Hokkaido University School of Medicine, N15 W7, 060-8638, Sapporo, Japan

    Kensuke Kameda, Ichiro Kusumi, Katsuji Suzuki, Jun Miura, Yuki Sasaki & Tsukasa Koyama

Authors
  1. Kensuke Kameda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ichiro Kusumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katsuji Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuki Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tsukasa Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kensuke Kameda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kameda, K., Kusumi, I., Suzuki, K. et al. Effects of citalopram on dopamine D2 receptor expression in the rat brain striatum. J Mol Neurosci 14, 77–86 (2000). https://doi.org/10.1385/JMN:14:1-2:077

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:14:1-2:077

Index Entries

Search

Navigation